BioMerieux reports encouraging first-half growth in 2015

BioMerieux has announced its financial results for the first six months of 2015, during which it generated a sales total of 933 million euros (684.77 million pounds).

This represented a year-on-year increase of 19.5 percent on a reported basis, or 8.1 percent in like-for-like terms. Meanwhile, a 34 percent improvement in contributive operating income was seen thanks to strong momentum, better management of expenses and positive currency impact.

Key highlights of the period include the sustained successful performance by FilmArray, the US approval of the Vidas 3 platform and the execution of the company's industrial investment plan.

Indeed,  FilmArray sales doubled year on year, allowing the installed base to be expanded to nearly 1,900 instruments.

As such, BioMerieux has been able to confirm its financial targets for the 2015 business year.

Alexandre Merieux, chief executive officer of BioMerieux, said: "The strong dynamic observed during the past six months reflects our broad geographic footprint and our diversified portfolio of solutions, which was recently enhanced with the acquisition of BioFire in molecular biology."